About ISCT

Partner Organizations

ISCT Co-Founded Organizations

Foundation for Accreditation of Cellular Therapy (FACT) logo

Foundation for Accreditation of Cellular Therapy (FACT)

Founded in 1996, the Foundation for Accreditation of Cellular Therapy (FACT) establishes standards for high quality medical and laboratory practice in cellular therapies. FACT is a non-profit corporation co-founded by the International Society for Cell and Gene Therapy (ISCT) and the American Society for Transplantation and Cellular Therapy (ASTCT), for the purposes of voluntary inspection and accreditation in the field of cellular therapy.

ISCT Board Representatives:

  • Ngaire Elwood, PhD
  • Patrick Hanley, PhD
  • Nadim Mahmud MD, PhD
  • Joseph Schwartz, MD, MPH
  • EJ Shpall, MD
  • Abba Zubair, MD, PhD
    View Website

    Joint Accreditation Committee-ISCT & EBMT (JACIE) logo

    Joint Accreditation Committee-ISCT & EBMT (JACIE)

    The Joint Accreditation Committee-ISCT & EBMT (JACIE) is a not-for-profit entity established in 1998 for the purposes of assessment and accreditation in the field of haematopoietic stem cell (HSC) transplantation. JACIE's primary aim is to promote high quality patient care and laboratory performance in haematopoietic stem cell collection, processing and transplantation centres through the development of global standards and an internationally recognised system of accreditation.

    ISCT Board Representatives:

    • Franco Bambi, MD
    • Fermin Sanchez-Guijo, MD, PhD
    View Website

    Other Partner Organizations

    AABB Logo

    AABB

    ISCT Representative, Uniform Donor History Questionnaire, CT Task Force: Phyllis Warkentin, MD

    ISCT Representative, Circular of Information Cell Therapy Task Force (COI CT): J Wade Atkins, MS, MT(ASCP), SB

    Resources: 

    View Website

    ARM Logo

    Alliance for Regenerative Medicine (ARM)

    ISCT and ARM signed a Memorandum of Understanding in 2016, granting reciprocal honorary memberships and facilitating collaboration between both organizations relevant to advancing the cell and gene therapy industry.
    View Website

    AND&tAT Logo

    Andalusian Network for the design and translation of Advanced Therapies (ANd&tAT)

    ISCT and the Andalusian Network for the design and translation of Advanced Therapies (ANd&tAT) collaborate on initiatives that will support the training and development of the next generation of cell and gene therapy professionals in Europe. ISCT proudly provided 3 full tuition scholarships for 3 ISCT Europe Members to enroll in the 2021/2022 Master in Manufacturing of Advanced Therapy Medicinal Products (ATMPs) at the University of Granada/ ANd&tAT. Currently ISCT and ANd&tAT are developing a series of on-line training modules covering cell and gene therapy manufacturing methods, quality assurance, product development pathways, GMP compliance, IMPD writing and biosafety – we look forward to launching this resource to the membership soon.


    View Website

    ASTCT Logo

    American Society for Transplantation and Cellular Therapy (ASTCT)

    ISCT and ASTCT co-founded FACT in 1996 and collaborate to deliver the bi-ennial Cell Therapy Training Course.


    View Website

    BAA Logo

    Biotherapeutics Association of Australasia (BAA)

    ISCT signed a Memorandum of Understanding with the BAA in 2016 to foster collaborations in cell and gene therapy in the Australia & New Zealand Region.

    ISCT Cellular Therapy Representative:
    Janice Fogarty, MSc


    View Website

    ABTCel-Gen Logo

    Brazilian Association of Cell and Gene Therapy (ABTCel-Gen)


    The partnership between ISCT and the Brazilian Association of Cell and Gene Therapy (ABTCel-Gen) aims to support the development of cell and gene therapies in Brazil and South & Central America through providing an increase in education, training, and networking opportunities and resources. Joint initiatives include organizing joint meetings and a membership referral program. ABTCel-Gen is an affiliate Society of Cytotherapy®, the Official Journal of ISCT.

    View Website

    CARM Logo

    Council for Advanced Regenerative Medicine (CARM)

    ISCT and CARM collaborate to advance the development of safe and effective cell and gene therapies in Korea and the Asia region. CARM and ISCT have collaborated on projects since 2014 and signed a Memorandum of Understanding (MOU) in 2018.

    CARM Representative on the ISCT Commercialization Committee:
    Antonio Lee, PhD


    View website

    Catapult Logo

    Cell and Gene Therapy Catapult

    ISCT has a long history of collaboration with the Cell & Gene Therapy Catapult since 2014, most notably through the ongoing Industry Networking Receptions at in-person ISCT Annual Meetings.

    View Website

    CellCAN Logo

    CellCAN Regenerative Medicine & Cell Therapy Network

    ISCT and CellCAN collaborate on projects that advance the regenerative medicine ecosystem in Canada, including the Early Stage Professionals Training & Workforce Development Survey. CellCAN has also been the lead organization of the Canadian Pavilion, a showcase of Canadian cell and gene therapy companies in the Exhibit Hall at ISCT Annual Meetings since 2017.


    View Website

    CBA Logo

    Cord Blood Association (CBA)

    ISCT and CBA collaborate on an Annual Cord Blood Connect workshop at the ISCT Annual Meeting, bringing together the global cord blood community.


    View Website

    EATRIS Logo

    European Infrastructure for Translational Medicine (EATRIS)

    ISCT and EATRIS signed a Memorandum of Understanding (MOU) in 2016 to foster collaboration and the advancement of cell and gene therapy translational research in Europe. 

    View Website

    EBMT Logo

    European Society for Blood and Marrow Transplantation (EBMT)

    Since 1998 with the creation of the Joint Accreditation Committee of ISCT and EBMT (JACIE), EBMT and ISCT and EBMT have been in dialogue and project- based partnerships. ISCT and EBMT signed an MOU in 2019 to facilitate continued global collaborations and projects.

    View Website

    FIRM Logo

    Forum for Innovative Regenerative Medicine (FIRM)

    ISCT and FIRM have collaborated since 2015 and signed a Memorandum of Understanding (MOU) in 2017 to promote the development of the cell and gene therapy ecosystem in Japan. 

    FIRM Representative on the ISCT Commercialization Committee:
    Yoshie Tsurumaki


    View Website

    ICCBBA Logo

    International Council for Commonality in Blood Banking Automation (ICCBBA)

    ISCT has a representative on the ICCBBAA Cellular Therapy Coding and Labelling Advisory Group, which was established in 2004.

    ISCT Representative, Cellular Therapy Coding and Labeling Group (CTLAG):
    Leigh Poston, BSc, MT(ASCP)

    View Website

    ISEV Logo

    International Society for Extracellular Vesicles (ISEV)

    Drawing on ISEV’s expertise as a world leader in basic science of extracellular vesicles and ISCT’s depth of expertise in the translation of cell and gene therapy, ISCT and ISEV signed a memorandum of understanding in 2020 to facilitate collaborations in the areas of unproven cell & gene therapies as well as translation of promising EV research to the clinic.

    View Website

    ISO Logo

    International Organization for Standardization (ISO)

    ISCT is a Category A liaison to the International Standards Organization, providing key expertise in areas of new cell and gene therapy related standards.

    ISCT Representative, Category A:

    Sowmya Viswanathan, PhD


    View Website
    JSRM_RGB_V.png

    The Japanese Society for Regenerative Medicine (JSRM)

    ISCT signed a memorandum of understanding with the Japanese Society for Regenerative Medicine in 2019 to advance regenerative medicine research towards a global audience. JSRM is the largest regenerative medicine society in the world (over 6,000 members) and ISCT provides an avenue for global translation.

    View Website

    Korean Society of Blood and Marrow Transplantation (KSBMT)

    ISCT has a long history of collaboration with KSBMT, bringing global translation expertise to the Korean BMT audience.

    View Website

    NASEM Logo

    The National Academies of Sciences Engineering Medicine (NASEM)

    ISCT is a member of the National Academies of Sciences, Engineering, and Medicine’s Forum on Regenerative Medicine. The Forum convenes academia, industry, government, patient and provider organizations, regulatory bodies, foundations, societies, associations, and others to discuss challenges facing the application of, and the opportunities for, regenerative medicine to improve health through the development of effective new therapies. 

    ISCT Representatives:

    • Daniel Weiss, MD, PhD
    • Patrick Hanley, PhD
      View Website

      The National Academies of Sciences Engineering Medicine (NASEM)

      ISCT is a member of the National Academies of Sciences, Engineering, and Medicine’s Forum on Regenerative Medicine. The Forum convenes academia, industry, government, patient and provider organizations, regulatory bodies, foundations, societies, associations, and others to discuss challenges facing the application of, and the opportunities for, regenerative medicine to improve health through the development of effective new therapies. 

      ISCT Representatives:

      • Daniel Weiss, MD, PhD
      • Patrick Hanley, PhD
        View Website
        SCB logo

        The Standards Coordinating Body(SCB)

        ISCT is a member of the Standards Coordinating Body for Gene, Cell, and Regenerative Medicines and Cell-Based Drug Discovery (SCB), supporting the development of standards and best practices that support the cell and gene therapy industry.

        ISCT Representative on the SCB Board of Directors:
        Kurt Gunter, MD


          View Website

          SCSS Logo

          Stem Cell Society Singapore (SCSS)

          ISCT most recently collaborated with the Stem Cell Society of Singapore on a joint regional meeting in 2019, prior to the pandemic. This collaboration also provided a joint membership program. We look forward to collaborating with SCSS again in the future.

          View website 

          SCRM Logo

          Strategic Center for Regenerative Medicine (SCRM)

          ISCT and SCRM collaborate to advance the development of safe and effective cell and gene therapies in Korea and the Asia region. SCRM and ISCT have collaborated on projects since 2014 and signed a Memorandum of Understanding (MOU) in 2018.

          SCRM Representative on the ISCT Commercialization Committee:
          Bryan Choi, PhD

          USP Logo

          United States Pharmacopeial Convention (USP)

          ISCT has been a voting member of USP since 2013.

          ISCT Representative:
          Joseph C. Laning, PhD


          View Website

          WBMT Logo

          Worldwide Network for Blood & Marrow Transplantation (WBMT)

          ISCT is a member Society of WBMT with an appointed representative who acts as the liaison between the two organizations. ISCT has also participated on the Alliance for Cellular Therapy Accreditation (AHCTA).

          ISCT Representative:
          Fermin Sanchez-Guijo, MD, PhD


          View Website

          WHO Logo

          World Health Organization (WHO)

          ISCT participates in expert consultation with the WHO International Nonproprietary Names (INN) Programme in the development of INN names for cell and gene therapy products.

          ISCT Representative:
          Massimo Dominici, MD

          View Website

          WMDA Logo

          World Marrow Donor Association (WMDA)

          ISCT and WMDA collaborate to promote education around stem cell and cord blood banking and transplantation. 

          View Website